CannIntelligence.com provides independent, in-depth regulatory and market data and intelligence for the global cannabis and cannabinoid sector.
LATEST ALERTS
View all Cannabis and cannabinoids in Utah
Regulatory reports
Comprehensive legal reports outlining how the sector is regulated, interpretation of the laws and relevant bodies
Regulatory databases
Regularly updated global regulations currently in place, compiled into easy-to-read maps and tables
New trial available: Click on any alert below and access our regulatory alerts and get timely notifications sent to your inbox for 7 days.
Daily news alerts
Our legal experts track the evolving regulation around the cannabinoid and cannabis sector on a daily basis. These alerts are then compiled into our Round-up section.
17th March 2023
US - Utah: Senate Bill (SB) 137 has been signed into law by the governor. SB 137 modifies the state's medical cannabis laws in several ways, including requiring terpene testing and disclosure of terpene profiles for certain products and extending the expiry date of initial issuances of medical cannabis cards from six months to one year, unless the practitioner recommends a shorter period.17th March 2023
- US - Utah: House Bill (HB) 72 has been signed into law by the governor. HB 72 makes various amendments to the state's medical cannabis programme, such as allowing for delivery of medical cannabis products directly from licensed processors under certain conditions and shifting regulation of pharmacies to the Department of Agriculture and Food. The bill also creates a Medical Cannabis Policy Advisory Board.
17th March 2023
- US - Utah: Senate Bill (SB) 91, has been signed into law by the governor. SB 91 changes the state’s medical cannabis laws in various ways, including removing a cap on the number of licences for testing laboratories, modifying and adding labelling requirements, and requiring heavy metal testing for vape cartridges.
24th February 2023
- US - Utah: Senate Bill (SB) 137 was amended and passed by the House and must now be reconciled by the Senate before going to the governor for final approval. SB 137 would modify the state's medical cannabis laws in several ways, including requiring terpene testing and disclosure of terpene profiles for certain products and extending the expiry date of initial issuances of medical cannabis cards from six months to one year, unless the practitioner recommends a shorter period.
20th February 2023
- US - Utah: The Senate amended and passed House Bill (HB) 72, so the Senate amendments must now be approved by the House. HB 72 would make various amendments to the state's medical cannabis programmes, such as allowing for delivery of medical cannabis products directly from licensed processors under certain conditions and shifting regulation of pharmacies to the Department of Agriculture and Food.
16th February 2023
US - Utah: Senate Bill 91, which was passed by the Senate last week, has been passed by the House with a minor amendment which will need to be approved by the Senate before going to the governor. The bill would change the state’s medical cannabis laws in various ways, including removing a cap on the number of licences for testing laboratories, modifying labelling requirements, and requiring heavy metal testing for vape cartridges.
15th February 2023
US - Utah: Senate Bill 137, which has been passed by the Senate and now heads to the House, would modify the state’s medical cannabis laws in several ways, including requiring terpene testing and disclosure of terpene profiles for certain products. It would also extend the expiry date of medical cannabis cards from six months to a year after issuing unless the practitioner recommends a shorter period.
7th February 2023
US - Utah: Senate Bill 91 has been passed by the Senate and now heads to the House. It would amend the state’s medical cannabis laws in various ways, including removing a cap on the number of licences for testing laboratories, modifying labeling requirements, and requiring heavy metal testing for vape cartridges.
19th January 2023
US - Utah: The House has passed House Bill 72 on medical cannabis governance, which now moves to the Senate. It would make various amendments to the state’s medical cannabis programs, such as allowing delivery of medical cannabis products directly from licensed processors under certain conditions, and shifting regulation of pharmacies to the Department of Agriculture and Food.
4th November 2022
- US - Utah: The Utah Department of Agriculture and Food (UDAF) issued a statement about synthetic and derivative cannabinoids, such as delta-8 THC and THC-O, appearing in retail channels and the state's medical cannabis programme. The statement acknowledged that products containing these cannabinoids have reached retail shelves as hemp products – despite the UDAF's enforcement efforts to prevent them as they are considered illegal under state law – and asked consumers to report the presence of such products by submitting a complaint online. The UDAF also provided explanations for how some of these cannabinoids entered the medical cannabis market and outlined its enforcement efforts.
20th July 2022
US - Utah: The Utah Department of Agriculture and Food (UDAF) has proposed new rules regarding hemp products and cannabis processing. Under the proposals, which are open to public comment until 15th August, hemp-derived cannabinoid products – which would include any THC analog such as delta-8 – could only contain up to 0.3% THC and from 1st December 2022 could contain only “a combined amount of total THC and any THC analog that does not exceed 10% of the total cannabinoid content”. The proposed rule expressly excludes some cannabinoids, such as CBD, CBG, and CBN, from being considered “THC analogs”.
